Development of HPLC for simultaneous analysis of quercetin and its degradation compound

Similar documents
RP- HPLC and Visible Spectrophotometric methods for the Estimation of Meropenem in Pure and Pharmaceutical Formulations

IJPAR Vol.3 Issue 4 Oct-Dec-2014 Journal Home page:

International Journal of Pharma and Bio Sciences DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF STRONTIUM RANELATE IN SACHET

Application Note. Agilent Application Solution Analysis of ascorbic acid, citric acid and benzoic acid in orange juice. Author. Abstract.

RP-HPLC Analysis of Temozolomide in Pharmaceutical Dosage Forms

F. Al-Rimawi* Faculty of Science and Technology, Al-Quds University, P.O. Box 20002, East Jerusalem. Abstract

Qualitative and quantitative determination of phenolic antioxidant compounds in red wine and fruit juice with the Agilent 1290 Infinity 2D-LC Solution

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

ISSN: ; CODEN ECJHAO E-Journal of Chemistry 2011, 8(3),

Rapid and sensitive UHPLC screening for water soluble vitamins in sports beverages

SUPPLEMENTARY MATERIAL Antiradical and antioxidant activity of flavones from Scutellariae baicalensis radix

SIMULTANEOUS ESTIMATION OF VALSARTAN AND HYDROCHLOROTHIAZIDE IN TABLETS BY RP-HPLC METHOD

Scholars Research Library. Der Pharmacia Lettre, 2016, 8 (6): (

Optimization of extraction method and profiling of plant phenolic compounds through RP-HPLC

Development and Validation for Simultaneous Estimation of Sitagliptin and Metformin in Pharmaceutical Dosage Form using RP-HPLC Method

Pelagia Research Library

Journal of Chemical and Pharmaceutical Research

International Journal of Pharma and Bio Sciences

Journal of Chemical and Pharmaceutical Research, 2017, 9(9): Research Article

Journal of Chemical and Pharmaceutical Research

Rapid Gradient and Elevated Temperature UHPLC of Flavonoids in Citrus Fruit

RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF BACLOFEN IN BULK AND PHARMACEUTICAL DOSAGE FORMS

Available online at Scholars Research Library

Hyderabad, India. Department of Pharmaceutical Chemistry, Glocal University, Saharanpur, India.

Rapid and sensitive UHPLC screening of additives in carbonated beverages with a robust organic acid column

UPLC/MS Monitoring of Water-Soluble Vitamin Bs in Cell Culture Media in Minutes

Development and validation of related substances method for Varenicline and its impurities

THE IDENTIFICATION OF PHENOLIC ACIDS BY HPLC METHOD FROM STRAWBERRIES. Abstract

Simultaneous Estimation of Gemcitabine Hydrochloride and Capecitabine Hydrochloride in Combined Tablet Dosage Form by RP-HPLC Method

Journal of Chemical and Pharmaceutical Research, 2013, 5(1): Research Article

A simple validated RP-HPLC method for quantification of sumatriptan succinate in bulk and pharmaceutical dosage form

Development, Estimation and Validation of Lisinopril in Bulk and its Pharmaceutical Formulation by HPLC Method

DETERMINATION OF LOTEPREDNOL ETABONATE AND TOBRAMYCIN IN COMBINED DOSAGE FORM USING RP-HPLC METHOD

CHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW

DEVELOPMENT AND VALIDATION OF COLORIMETRIC METHODS FOR THE DETERMINATION OF RITONAVIR IN TABLETS

Simultaneous estimation of Metformin HCl and Sitagliptin in drug substance and drug products by RP-HPLC method

A New Stability-Indicating and Validated RP-HPLC Method for the Estimation of Liraglutide in Bulk and Pharmaceutical Dosage Forms

Amudha S et al., Asian Journal of Pharmthiaceutical Technology & Innovation, 04 (21); 2016; Research Article

MEDAK DIST. ANDHRA PRADESH STATE, INDIA. Research Article RECEIVED ON ACCEPTED ON

METHOD DEVELOPMENT AND VALIDATION BY RP-HPLC FOR ESTIMATION OF ZOLPIDEM TARTARATE

Development and validation of stability indicating RP-LC method for estimation of calcium dobesilate in pharmaceutical formulations

Pelagia Research Library

A HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC ASSAY FOR LERCANIDIPINE HYDROCHLORIDE

ISSN (Print)

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

CHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW

Selectivity Comparison of Agilent Poroshell 120 Phases in the Separation of Butter Antioxidants

SIMULTANEOUS DETERMINATION OF ATORVASTATIN AND EZETIMIBE BY RP-HPLC IN PURE AND PHARMACEUTICAL DOSAGE FORM

Sanjog Ramdharane 1, Dr. Vinay Gaitonde 2

Development and Validation of RP-HPLC Method for the Estimation of Gemigliptin

World Journal of Pharmaceutical Research

DETERMINATION OF OXYCODONE CONTENT AND RELATED SUBSTANCES IN OXYCODONE AND ACETAMINOPHEN CAPSULE BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY

Available online Research Article

Journal of Chemical and Pharmaceutical Research, 2018, 10(3): Research Article

J Pharm Sci Bioscientific Res (4): ISSN NO

AMERICAN JOURNAL OF BIOLOGICAL AND PHARMACEUTICAL RESEARCH

Pankti M. Shah et al, Asian Journal of Pharmaceutical Technology & Innovation, 04 (17); 2016; 07-16

Stability indicating RP-HPLC method for simultaneous determination of Beclomethasone Dipropionate and Clotrimazole from dosage form

36 J App Pharm Vol. 6; Issue 1: 36-42; January, 2014 Rao et al., 2014

Research Article Derivative Spectrophotometric Method for Estimation of Metformin Hydrochloride in Bulk Drug and Dosage Form

An Investigative Study of Reactions Involving Glucosinolates and Isothiocyanates

CHAPTER 8 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) ANALYSIS OF PHYTOCHEMICAL CONSTITUENTS OF M. ROXBURGHIANUS AND P. FRATERNUS PLANT EXTRACTS

Tentu Nageswara Rao et al. / Int. Res J Pharm. App Sci., 2012; 2(4): 35-40

Determination of Tetracyclines in Chicken by Solid-Phase Extraction and High-Performance Liquid Chromatography

CHAPTER 2 SIMULTANEOUS DETRMINATION OF ANASTROZOLE AND TEMOZOLOMIDE TEMOZOLOMIDE CAPSULES 20 MG AND ANASTROZOLE TABLETS 1 MG

HPLC-UV Determination of Abacavir Sulphate in Pharmaceutical Dosage Forms

Increasing resolution using longer columns while maintaining analysis time Advantages of the wide power range of the Agilent 1290 Infinity LC System

International Journal of Medicine and Pharmaceutical Research. International Journal of Medicine and Pharmaceutical Research

RITONAVIRI COMPRESSI RITONAVIR TABLETS. Final text for addition to The International Pharmacopoeia (July 2012)

Analysis of Isoflavones with the PerkinElmer Flexar FX-15 UHPLC System Equipped with a PDA Detector

CYCLOSERINI CAPSULAE - CYCLOSERINE CAPSULES (AUGUST 2015)

Estimation of Emtricitabine in Tablet Dosage Form by RP-HPLC

Available online Research Article

RP-HPLC Method Development and Validation of Abacavir Sulphate in Bulk and Tablet Dosage Form

INTERNATIONAL JOURNAL OF PHARMACY & LIFE SCIENCES

Scholars Research Library. Der Pharmacia Lettre, 2015, 7 (5):44-49 (

A Validated Chiral Liquid Chromatographic Method for The Enantiomeric Separation of Dapoxetine Hydrochloride

Development and Validation of Stability Indicating HPLC method for Determination of Eperisone HCL in Bulk and in Formulation

A stability indicating RP-HPLC method for simultaneous estimation of darunavir and cobicistat in bulk and tablet dosage form

Journal of Chemical and Pharmaceutical Research, 2018, 10(2):1-5. Research Article. RP- HPLC Method for Estimation of Furosemide in Rabbit Plasma

PROPOSAL FOR REVISION OF MONOGRAPH PUBLISHED IN The International Pharmacopoeia: REVISION OF ph test ABACAVIR ORAL SOLUTION (JULY 2012)

Development and validation of RP-HPLC method for simultaneous estimation of gliclazide and metformin in pure and tablet dosage form

NOVEL RP-HPLC METHOD. B.Lakshmi et a. concentration range KEY INTRODUCTION. Diltiazem is used to. . It works by of contractionn of the. (dilate).

Enhancement of flavonols water solubility by cyclodextrin inclusion complex formation - case study

vii LIST OF TABLES TABLE NO DESCRIPTION PAGE 1.1 System Suitability Parameters and Recommendations Acidic and Alkaline Hydrolysis 15

PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES

Volume 2 (6), 2014, Page CODEN (USA)-IJPRUR, e-issn: International Journal of Pharma Research and Health Sciences

TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010)

REVERSE PHASE HPLC METHOD FOR THE ANALYSIS OF ALFUZOSIN HYDROCHLORIDE IN PHARMACEUTICAL DOSAGE FORMS

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR QUANTITATIVE ANALYSIS TOLBUTAMIDE IN PURE AND PHARMACEUTICAL FORMULATIONS

Journal of Chemical and Pharmaceutical Research

Pelagia Research Library

438 Full Text Available On


Int. J. Pharm. Sci. Rev. Res., 30(1), January February 2015; Article No. 32, Pages:

Reverse Phase HPLC Analysis of Atomoxetine in Pharmaceutical Dosage Forms

Development and Validation of RP-HPLC Method for the Simultaneous Estimation of Haloperidol and Trihexyphenidyl in API and Combined Tablet Dosage Form

Maximizing chromatographic peak capacity with the Agilent 1290 Infinity LC system

Journal of Pharmacreations

Continuation of Reversed-Phase HPLC Analysis Studies of Steviol Glycosides Isolated From Stevia rebaudiana Bertoni

Transcription:

Development of HPLC for simultaneous analysis of quercetin and its degradation compound ก ก ก กก ก Saengrawee Sutthiparinyanont ( )* Dr.Aroonsri Priprem (. )** Dr. Malyn Chulasiri (. )*** Chidchanok Khamlert ( ก )**** ABSTRACT A gradient system high performance chromatography (HPLC) for simultaneous deteration of quercetin and protocatechuic acid (PA), its major degradation compound in an aqueous system, was developed for stability studies. Results obtained from the HPLC analysis was compared with antioxidant activity test by DPPH assay. The ratio of mobile phase, consisted of methanol/acetonitrile and phosphoric acid, were varied in binary and ternary systems. The optimum conditions were found in ternary mobile phase system of methanol:acetonitrile:25mm phosphoric acid with gradient program from 50:0:50 to 40:20:40, respectively. Using the developed HPLC system to analyze standard solutions of quercetin mixed with PA gave high relative coefficient (r 2 >0.99), with an approximate detection limit of 0.05 µg/ml of quercetin and 0.025 µg/ml PA, good precision (%CVs<10), and relatively high percent recovery (>87%). The developed HPLC could simultaneously use to separate quercetin and PA. Quantitative analysis by this highly sensitive method gave reliable, reproducible, precise and rapid results. Moreover, the antioxidant testing results by DPPH exhibits a good correlation with the quantitative analysis by the HPLC. This developed method is useful for further study required for pharmaceutical product development. ก (HPLC) ก (gradient) ก ก ก (PA) ก กก ก ก ก ก ก ก กก HPLC ก ก ก ก DPPH assay ก 2 3 ก ก / ก ก ก PA ก 3 ก ก 25 ก 50:0:50 40:20:40 ก PA (r 2 >99) ก ก *Student, Doctor of Philosophy Program in Research and Development in Pharmaceuticals, Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, Thailand **Associate Professor, Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, Thailand ***Professor, Research & Development Division, SJI, Bangkok, Thailand ****M.D., Master of Science Program in Pharmaceutical Chemistry and Natural, Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, Thailand

0.05 ก 0.025 ก PA (%CVs<10) ก ก (>87%) ก ก ก ก ก ก DPPH assay ก กก HPLC ก ก ก ก ก ก Key Words: Quercetin, Protocatechuic acid, HPLC, Stability : ก ก ก Introduction Quercetin, 3,5,7,3,4 -pentahydroxyl flavone (Figure 1), a flavonol compound generally found in fruits, and vegetables such as onions, apple, tea, and red wines, is a potentially effective antioxidant. It has been interested for health product development for nutraceutical and pharmaceutical uses because of its potent antioxidant, antihistae, antimicrobial and anti-inflammatory properties (Formica and Regelson, 1995; Bonina et al., 1996; Ratnam et al., 2006). H (a) 6 7 8 1' A 5 4 C 3 2 2' B 6' 3' Figure 1 Structure of quercetin (a) and protocatechuic acid (b) (Makris and Rossiter, 2001) 4' 5' Figure 2 shows the degradation pathways of quercetin in the presence of hydroxyl ion. It is postulated that its degradation would affect its efficacy for health benefit. That activity may lead quercetin to the benefits in preventing serious diseases. Quercetin can be degraded via oxidative cleavage pathway under certain accelerated oxidative (b) H conditions (Makris and Rossiter 2002; Pinelo et al. 2004). To evaluate a stability profile of quercetin, which is very important for quality control of its product development and production process, a reliable quantitative analysis method is needed. Protocatechuic acid (PA) is one of major degradation product of quercetin, which has been reported to be a prooxidant (Makris and Rossiter, 2001; Cao et al., 1997). The production of PA as shown in Figure 2 would occur in aqueous rather than non-aqueous solutions. The presence of PA could be an indication of the degradation of quercetin. Most of the production and quality control of health products deals with aqueous solutions, thus, this study was intended to perform by using water as the medium for quercetin. H Quercetin xidative cleavage -2e - -2H + +2e - +2H + H H H H Phloroglucinol carboxylic acid H H H Protocatechuic acid Figure 2 xidative cleavage of quercetin. (Makris and Rossiter, 2002)

Simultaneous analysis of quercetin alone and quercetin with PA was studied in various samples such as fruits, some food and wine as it is the index. Studies by using high performance liquid chromatography (HPLC) were numerous. Quercetin alone was reported to be analyzed by various systems including isocratic mobile phase system such as Wach et al. (2007) used the mixture of HCl:methanol (60:40) and Careri et al. (2000) used the mixture of formic acid:acetronitrile (80:20). Moreover, the analysis has also been reported by using gradient mobile phase system such as mixture of phosphoric acid and methanol with gradient from 82% to 55% of phosphoric acid (Ye et al., 2002), and mixture of formic acid and acetronitrile with gradient from 50% to 65% of acetronitrile (Careri et al., 2000). The lowest limit of detection of quercetin from these reports was in the range of 64 ng/ml, and the fastest retention time of quercetin being about 5 (Ye et al., 2002). There were 2 reports on simultaneous deteration has been detered quercetin and PA being as follows. Conde et al. (1995) developed HPLC gradient system of methanol, acetronitrile and water mixture which could complete a simultaneous analysis of quercetin and PA within 21. While the system from Makris and Rossiter (2002) eluted the compound by the gradient system of acetronitrile and phosphoric acid mixture which could complete a simultaneous analysis of quercetin and PA within 90 at 40 C. However, these systems were reported for qualitative analysis with little or none information for further quantitative measurement for quality control of health products. Also, an HPLC which performed at room temperature would be preferable than the previous report with higher temperature. Quantitative analysis of a parent and its degradation compounds in the same environment is essential for the monitoring of stability, particularly compounds with a rapid oxidative degradation. Thus, there is a need to develop an HPLC which would be simultaneous analysis for quercetin and its degradation compound. This present study was aimed to develop HPLC system for simultaneous and quantitative deteration of both quercetin and PA. The developed HPLC system was then used to study the effect of solvent on immediately quercetin stability. The study was carried out by correlate of quantitative developed HPLC method and antioxidant activity testing by DPPH (2,2-diphenyl-1-picrylhydrazyl) assay in order to measure the quantitative of quercetin to scavenge stable DPPH free radical. The HPLC method would be validated and tested as a quantitative tool for detection of quercetin and PA in water. Materials and Methods 1. Materials Quercetin dihydrate, >98% purity and 3,4- dihydroxybenzoic acid (proto- catechuic acid, PA), and DPPH (2,2-diphenyl-1-picrylhydrazyl) were purchased from Sigma (St. Louis, Mo, USA). Methanol (Me) and acetronitrile (ACN) for HPLC analysis was from BDH (Poole, UK). Absolute ethanol and ortho phosphoric acid in reagent grade were from Merck (Damstadt, Germany). 2. Development of HPLC systems for the deteration of quercetin and protocatechuic acid 2.1 Concentration of phosphoric acid

The concentration of phosphoric acid was varied in order to optimize the mobile phase system, whereas the ratio of Me and phosphoric acid were fixed 60:40 ratio which modified from Ye et al. (2002). Molar concentration of phosphoric acid was varied to be 2.5, 12.5, and 25 mm. Quercetin and PA standard at 100 µg/ml prepared in ethanol, was used. The flow rate of the mobile phase was 1.0 ml/ with an injection volume at 20 µl. Quercetin and PA were detected at 294 nm by UV-visible detector. 2.2 Ratio of methanol and phosphoric acid This was an attempt to optimize the molar ratio of Me:phosphotic acid for high performance of the analysis. Ratios of Me: phosphotic acid being tested was 40:60, 50:50, 60:40, and 70:30 with isocratic system. Quercetin 100 µg/ml was injected at 20 µl and the elution was carried out with flow rate at 1.0 ml/ and detected by UV-Visible detector (294 nm). 2.3 Ratio of acetronitrile and phosphoric acid This was an attempt to optimize the molar ratio of ACN: phosphotic acid for high performance of the analysis. Ratios of ACN: phosphotic acid being tested was 40:60, 50:50, 60:40, and 70:30 with isocratic system. Quercetin standard at 100 µg/ml was injected at 20 µl and the elution was carried out with flow rate at 1.0 ml/ and detected by UV- Visible detector (294 nm). 2.4 Ternary mobile phase system Results from 2.1-2.3 were used to select a range of ratio of Me:ACN: phosphotic acid, in both isocratic and gradient systems. The ratio of Me:ACN: phosphoric acid for isocratic system was varied by 55:15:30, 45:25:30, 35:35:30, 50:10:40, 40:20:40, and 30:30:40. Then, gradient system was carried out by the elution program of system I (30:30:40 to 50:10:40), system II (50:0:50 to 40:20:40), and system III (40:20:40 to 60:0:40). 3. Validation of quercetin analysis 3.1 Standard curve and linearity Linearity of this study responded to different concentrations of the quercetin and PA standards were detered at 0.03, 0.05, 0.08, 0.1 and 4 µm. Calibration curves were linear over the investigating range when peak areas were plotted against concentrations followed a least square regression analysis. 3.2 Precision Quercetin and PA at 0.1 and 6 µg/ml were freshly prepared and repeatedly analyzed in 3 consecutive days, 5 times in a day and each analysis being 3 hours apart (five times per day with 3 hours difference). This experiment was performed 3 consecutive days. The injection volume and the flow rate were the same as described at room temperature. 3.3 Recovery The relative recovery for quercetin and PA was assessed with low and high concentrations level at 0.1 and 6 µg/ml. Each concentration of quercetin sample was spiked into various concentrations of quercetin and PA, and then was analyzed. 3.4 Limit of detection Quercetin and PA were prepared at various concentrations to detere the limit of detection of both compounds.

4. Effect of solvent on quercetin Quercetin and PA were prepared in ethanol at concentration of 20 µg/ml. Quercetin in ethanol was compared with quercetin in water. Quercetin in water system was prepared by lower concentration at 0.1 µg/ml based on its solubility. Each solution was kept in brown glass bottle for light protection at 27±1ºC. The quantity and antioxidant activity was analyzed by developed HPLC and DPPH assay, respectively. 5. Antioxidant activity testing The antioxidant activities of quercetin were assayed by modified from the DPPH assay described (Casagrande et al., 2007), the details being as follows. Quercetin and PA were separately dissolved in water and ethanol. Thereafter, the series were adjusted by methanol and finally added DPPH solution. Precisely 15 after DPPH was added, each mixture solution was measured an absorbance at 515 nm using the UV spectrophotometer. Each sample solution was prepared with 6 concentration series, each of which was subjected to linear regression analysis and the concentration of quercetin or PCA which exerts 50% antioxidant activities was evaluated as shown by this following equation: The results were reported by concentration of samples at 50% inhibition, called IC 50 % inhibition = [(Abs control Abs sample )/Abs control ] x 100 6. Statistical analysis The results reported in this work are the averages and the coefficients of variations, expressed as the percentage ratio between standard deviations and the mean values, and independent t-test for validation and comparison in stability studies. Results and Discussion 1. Development of HPLC system 1.1 Concentration of phosphoric acid Various phosphate buffer concentrations 2.5, 12.5, and 25 mm verified by HPLC, was optimized to maintain the ph value and reduced the effect of ionic strength. Figures 3 and 4 present the chromatograms of quercetin and protocatechuic acid (PA) with 3 concentrations of phosphoric acid concentration. As concentration of phosphoric acid increased from 2.5 to 25 mm the retention times of the chromatograms of quercetin and phosphoric acid increased. However, these remain good separation, suggesting that concentration of phosphoric acid did not affect the separation with retention behavior around 3.5 and 7 for PA and quercetin, respectively. It can be inferred that ionic strength is less effect for HPLC analysis in this study. In order to reduce the ionization of phenol groups, the highest phosphoric acid was selected so that the flavonols and their glycosides could be separated much better. - 25 mm - 12.5 mm - 2.5 mm Figure 3 HPLC chromatograms of quercetin using mobile phase Me:phosphoric acid with concentrations of phosphoric acid of 2.5, 12.5 and 25 mm.

- 25 mm - 12.5 mm - 2.5 mm Figure 4 HPLC chromatograms of PA using mobile phase Me:phosphoric acid with concentrations of phosphoric acid of 2.5, 12.5 and 25 mm 1.2 Effect of Me/ACN and phosphoric acid ratio Four various ratio of the mixture were carried out to detere the appropriate ratio of Me/acetronitrile (ACN) and phosphoric acid for quercetin and PA analysis rather stepwise 40:60, 50:50, 60:40, 70:30. The results are shown in Figure 5 and 6. In the system of methanol: phosphoric acid, an increase of methanol percentage gave the higher symmetric chromatograms at almost the same time around 7. While, in the system of ACN:phosphoric acid, symmetric chromatograms were occurred when reduce. The retention time was higher in the system containing lower percentage of ACN. - 50:50-60:40-70:30 Figure 5 HPLC chromatograms of quercetin using mobile phase Me:phosphoric acid with ratio of 50:50, 60:40 and 70:30 Figure 6 HPLC chromatograms of quercetin using mobile phase Me:phosphoric acid with ratio of 50:50, 60:40 and 70:30 Ternary mobile phase system (Me:ACN:phosphoric acid) was then optimized of separation condition in isocratic and gradient systems. An increasing ratio of phosphoric acid retained the chromatogram to longer time, but in contrast in the ratio of ACN (Figure7). Figure 7-70:30-60:40-50:50-40:60-55:15:30-45:25:30-35:35:30-50:10:40-40:20:40-30:30:40 HPLC chromatograms of quercetin using mobile phase Me:ACN:phosphoric acid with various isocratic ratio Finally gradient elution was carried out to ensure that each compound separate completely. Figure 8 showed chromatograms of mixed standards and the samples that could be completely separated within 15. Gradient system II [50:0:50 (3 ), 60:0:40 (3 ), 55:5:40 (3 ), 50:10:40 (3 ), 40:20:40 (3 )], revealed good separation and analysis, was then validated and used as optimized condition for stability study. Moreover, the quercetin and PA analysis using this developed condition spend

shorter time than previously study which they were eluted by UV detector at 325 nm which found chromatogram of quercetin and PA at around 21 and 5, respectively (Conde et al., 1995). In addition, quercetin and PA were detered by HPLC with UV detection at 290 nm, fixed mobile phase system at the ratio of phosphoric acid and acetronitrile (40:60), and also gradient percentage of acetronitrile from 40% to 20%. The chromatogram of quercetin and PA were found at 45 and 12, respectively (Makris and Rossiter, 2002). PA Quercetin Figure 8 HPLC chromatograms of quercetin using mobile phase Me:ACN:phosphoric acid ratio with gradient system II Me: phosphoric acid with 2. Validation of the developed HPLC system The standard range of quercetin or PA was checked and showed that linear correlations were obtained. The slope quercetin or PA was found at 0.9972 with linear equation of y = 15.024x + 17 for quercetin and y = 31.122x - 90.535 (r 2 = 0.9925) for PA. Within-day repeatability and reproducibility of the method, carried out with 0.1 and 6 µg/ml of quercetin gave the average CVs of less than 3% and 10% for 0.1 and 6 µg/ml, respectively. This indicates that the developed HPLC method is repeatable and reproducible. The relative recovery was in the range between 87 to 91%. The limit of detection (LD) for a signal-to-noise ratio of 3:1 was 0.05 µg/ml. That is reliable for use for simultaneous analysis quercetin and PA in other sample. 3. Stability of quercetin and PA in content and antioxidant activity The developed HPLC method was attempted for use in the detection of quercetin and PA in commonly used solvents, such as water and ethanol. The focus of the analysis was based on quercetin as it is the parent compound and the deteration of PA was performed as a by-product of analysis. Figure 9 shows an antioxidant activity of sample to inhibit free radical at different concentration by using DPPH assay. At fifty percentages of inhibition as IC 50 value present the potential of quercetin and PA as showed in Table 1 and32. %Inhibition 70 60 50 40 30 20 10 0 y = 14.119x - 1.4156 R 2 = 0.9995 0 1 2 3 4 5 Concentration (ug/ml) Figure 9 Inhibition curve of quercetin in ethanol to inhibit DPPH free radical by DPPH assay Changes in the quantity and antioxidant activity of an ethanol solution containing 20 µg/ml quercetin and PA during storage at ambient temperature are shown in Table 1. The results show that the quantity and antioxidant activity of both

compounds in ethanol revealed significantly difference from an initiation time since 2 h for PA and 4 h for quercetin. The change of smaller structure of PA showed the degradation was more rapid than quercetin. The decrease in quantity from an initiation time did correspond to any appreciable change in antioxidant activity. Antioxidant activity will reduce (IC 50 increase) follow by the decrease in quantity. This correlation results about quantity and antioxidant behavior of quercetin as well as PA solutions, evaluate the developed analysis method confirmed by an activity test. PA is one of degradation product of quercetin by oxidative cleavage pathway (Figure 9), it showed to exert high potential inhibit free radical almost the same activity with quercetin. Table Quantity and antioxidant activity change of quercetin and PA in ethanol solution Time (h) Quercetin Quantity (µg/ml) Quercetin PA Remark: ND = not detectable *, #, significantly Antioxidant activity by DPPH (IC 50) 0 18.6 ± 0.11 ND 3.64 ± 0.06 2 18.9 ± 0.06 ND 3.63 ± 0.04 4 18.6 ± 0.14 ND 3.84 ± 0.07 * Protocatechuic acid, PA 0 ND 18.7 ± 0.09 3.80 ± 0.13 2 ND 18.5 ± 0.06 4.03 ± 0.04 # 4 ND 18.4 ± 0.06 4.58 ± 0.09 # Water 0 0.079 ± 0.005 * ND 3.80 ± 0.04 2 0.048 ± 0.002 * ND 3.85 ± 0.07 4 0.058 ± 0.004 * ND 3.61 ± 0.05 different (p<0.05) In aqueous solution, the stability of quercetin containing 0.1 µg/ml in water based on quercetin s solubility, Changes in quantity and antioxidant activity of quercetin in water systems during storage at the ambient temperatures (27±1ºC) for 4 h are reported in Table. ver 25% decrease of quantity was observed in water after two hours of storage time. Water solution of quercetin revealed antioxidant activity almost the same as in ethanol solution. The quercetin antioxidant activity can also be emphatically affected by polarity of solvent (Pinelo et al., 2004). Some recently researches reported that the antioxidant activity of quercetin in ethanol solution was near twice higher than that observed in the organic solvent, which presents an important polar group (van der Berg et al., 1999; Pinelo et al., 2004). These data especially in water system are not in agreement with the typical behavior of quercetin, whose chemical oxidation promotes the oxidative cleavage reaction giving two major products (Figure 2) which this study used only protocatechuic acid as an index to confirm this degradation pathway. Due to the time of this study was quite short (4 h). Consequently it required to extend for longer time to clear the understanding of the behavior of quercetin degradation in aqueous system. Conclusion The developed HPLC method was validated and proved to be reproducible, reliable and accurate. It could simultaneous detere quercetin and PA from one sample by using HPLC with simple UV detector. Both compound completely eluted by ternary mobile phase of methanol, acetronitrile, and phosphoric acid with gradient program from 50:0:50 to 40:20:40 ratio. The analysis takes less than 15

to detere both substances which was faster than the systems from previous study (Conde et al., 1995; Makris and Rossiter, 2002). The quantitative analysis was confirmed by DPPH. It is concluded that the change of quantity related to antioxidant activity. Therefore, this developed HPLC analysis method is useful for further pharmaceutical, cosmeceutical, and nutraceutical product development including stability testing. Acknowledgements The authors are grateful to National Research Council of Thailand (NRCT); Center of Excellence in Forum of Theoretical Science (CE- FTS), Chulalongkorn University for excellent coordination and Faculty of Pharmaceutical Sciences, Khon Kaen University. References Bonina, F., Lanza, M., Montenegro, L., Puglisi, C., Tomaino, A., Trombetta, D., Castelli, F. and Saija, A. 1996. Flavonoids as potential agents against photo-oxidative skin damage. Int. J. Pharm. 145, 87 94. Cao, G., Sofic, E., and Prior, R.L. 1997. Antioxidant and prooxidant behavior of flvonoids: structure-activity relationships. Free Rad. Bio. Med. 22(5), 749-760. Careri, M., Elviri, L., Mangia, A., and Musci, M. 2000. Spectrophotometric and coulometric detection in the high performance liquid chromatography of flavonoids and optimization of sample treatment for the deteration of quercetin in orange juice. J. Chromatogra. A. 881, 449 460. Casagrande, R., Georgetti SR, Verri Jr WA, et al. 2007. In vitro evaluation of quercetin cutaneous absorption from topical formulations and its functional stability by antioxidant activity. Int J Pharm. 328,183-190. Conde, E., Cadahfa, E., and Garcia-Vallejo, M.C. 1995. HPLC analysis of flavonoids and phenolic acids and aldehydes in Eucalyptus spp. Chromatographia. 41(11/12), 657-660. Formica, J.V. and Regelson, W. 1995. Review of the biology of quercetin and related bioflavonoids. Food Chem. Toxicol. 33(12), 1061-1080. Makris, D.P. and Rossiter, J.T. 2001. Comparison of quercetin and a non-orthohydroxy flavonol as antioxidants by competing in vitro oxidation reactions. J. Agric. Food Chem. 49, 3370-3377. Makris, D.P. and Rossiter, J.T. 2002. Hydroxyl free radical-mediated oxidative degradation of quercetin and morin:a preliary investigation. J. Food Composit. Anal. 15, 103-113. Pinelo, M., Manzocco, L., Nuñez, MJ. and Nicoli, MC. 2004. Solvent effect on quercetin antioxidant capacity. Food Chem. 88, 201 207. Ratnam, V.D., Ankola, D.D., Bhardwaj, V., Sahana, D.K. and Ravi Kumar, M.N.V. 2006. Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective. J. Control. Rel. 113, 189 207.

van der Berg, R., Haenen, G.R.R.M., Van der Berg, M., and Bast, A. 1999. Applicability of an improved Trolox equivalent antioxidant capacity (TEAC) assay for evaluation of antioxidant capacity measurements of mixtures. Food Chem. 66, 511 517. Wach, A., Pyrzyńska, K., and Biesaga, M. 2007. Quercetin content in some food and herbal samples. Food Chem. 100,699 704. Ye, M., Li, Y., Yan, Y., Liu, H., and Ji, X. 2002. Deteration of flavonoids in Semen Cuscutae by RP-HPLC. J. Pharm Biomed Anal. 28, 621 628.